Kappa opioid receptor internalisation-induced p38 nuclear translocation suppresses glioma progression
Yong Li1, Wenying Wang2, Han She1
1Department of Anesthesiology, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Background:
Recent studies have implicated a role for perioperative medications in determining patient outcomes after surgery for malignant tumours, including relapse and metastasis.
Methods:
A combined approach spanned molecular, cellular, and organismal levels, including bioinformatics, immunohistochemical staining of clinical and animal samples, RNA sequencing of glioblastoma multiforme (GBM) cells with Ingenuity Pathway Analysis, lentiviral-mediated gene expression modulation, in vitro cell experiments, and in vivo orthotopic tumour transplantation.
Results:
We observed a significant correlation between increased kappa opioid receptor (KOP receptor) expression and better prognosis in patients with glioma. Exogenous KOP receptor overexpression in GBM cells in vitro induced cell cycle arrest, suppressed cell growth, and promoted apoptosis. Conversely, reducing KOP receptor expression in GBM cells reduced the proportion of cells in S and G2/M phases, accelerating cell growth. KOP receptor overexpression inhibited glioma cell growth and prolonged survival in mice in vivo, while KOP receptor knockdown had the opposite effect. Mechanistically, internalised KOP receptors were found to bind cytoplasmic p38, facilitating its nuclear translocation and phosphorylation, which influences downstream gene expression. The selective KOP receptor agonist TRK-820 triggered KOP receptor internalisation, activated the p38 pathway, and diminished glioma cell viability in vitro.
Conclusions:
This combined molecular, cellular, and in vivo approach supports use of KOP receptor agonists as potential adjuvant therapeutics for glioma.
Insights
Increased kappa opioid receptor (KOP receptor) expression correlates with better glioma prognosis. KOP receptor agonists show potential as adjuvant therapies, inhibiting tumor growth and promoting apoptosis in preclinical models.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Pharmacology
Background:
- Perioperative medications may influence outcomes in malignant tumor surgery, including cancer recurrence and metastasis.
- Glioma, a primary brain tumor, presents significant therapeutic challenges.
Purpose of the Study:
- To investigate the role of kappa opioid receptor (KOP receptor) in glioma progression and therapeutic potential.
- To elucidate the molecular mechanisms underlying KOP receptor's effect on glioma cells.
Main Methods:
- Utilized a multi-level approach: bioinformatics, immunohistochemistry, RNA sequencing, gene expression modulation, in vitro cell assays, and in vivo orthotopic tumor transplantation.
- Examined KOP receptor expression in clinical glioma samples and animal models.
- Investigated the impact of KOP receptor manipulation on glioblastoma multiforme (GBM) cell behavior and tumor growth.
Main Results:
- Higher KOP receptor expression was significantly associated with improved prognosis in glioma patients.
- KOP receptor overexpression in GBM cells inhibited proliferation, induced cell cycle arrest, and promoted apoptosis in vitro.
- In vivo studies demonstrated that KOP receptor overexpression suppressed glioma growth and extended survival in mice.
- Mechanistically, KOP receptor activation led to p38 pathway phosphorylation, influencing downstream gene expression.
Conclusions:
- Findings support the potential of KOP receptor agonists as adjuvant therapeutic agents for glioma.
- Targeting the KOP receptor pathway may offer a novel strategy to improve glioma treatment outcomes.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
GPCR Desensitization
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...


